226 related articles for article (PubMed ID: 20498653)
1. Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury.
Hsu D; Fukata M; Hernandez YG; Sotolongo JP; Goo T; Maki J; Hayes LA; Ungaro RC; Chen A; Breglio KJ; Xu R; Abreu MT
Lab Invest; 2010 Sep; 90(9):1295-305. PubMed ID: 20498653
[TBL] [Abstract][Full Text] [Related]
2. The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia.
Hernandez Y; Sotolongo J; Breglio K; Conduah D; Chen A; Xu R; Hsu D; Ungaro R; Hayes LA; Pastorini C; Abreu MT; Fukata M
BMC Gastroenterol; 2010 Jul; 10():82. PubMed ID: 20637112
[TBL] [Abstract][Full Text] [Related]
3. Evolution of the predictive markers amphiregulin and epiregulin mRNAs during long-term cetuximab treatment of KRAS wild-type tumor cells.
Oliveras-Ferraros C; Massaguer Vall-Llovera A; Carrion Salip D; Vazquez-Martin A; Cufí S; Queralt B; Martin-Castillo B; Brunet J; de Llorens R; Menendez JA
Invest New Drugs; 2012 Apr; 30(2):846-52. PubMed ID: 21161326
[TBL] [Abstract][Full Text] [Related]
4. A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.
Ungaro R; Fukata M; Hsu D; Hernandez Y; Breglio K; Chen A; Xu R; Sotolongo J; Espana C; Zaias J; Elson G; Mayer L; Kosco-Vilbois M; Abreu MT
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1167-79. PubMed ID: 19359427
[TBL] [Abstract][Full Text] [Related]
5. MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands.
Brandl K; Sun L; Neppl C; Siggs OM; Le Gall SM; Tomisato W; Li X; Du X; Maennel DN; Blobel CP; Beutler B
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19967-72. PubMed ID: 21041656
[TBL] [Abstract][Full Text] [Related]
6. Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis.
Oshima H; Popivanova BK; Oguma K; Kong D; Ishikawa TO; Oshima M
Cancer Sci; 2011 Apr; 102(4):713-9. PubMed ID: 21205091
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells.
Miyazaki Y; Hiraoka S; Tsutsui S; Kitamura S; Shinomura Y; Matsuzawa Y
Gastroenterology; 2001 Jan; 120(1):108-16. PubMed ID: 11208719
[TBL] [Abstract][Full Text] [Related]
8. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development.
Luetteke NC; Qiu TH; Fenton SE; Troyer KL; Riedel RF; Chang A; Lee DC
Development; 1999 Jun; 126(12):2739-50. PubMed ID: 10331984
[TBL] [Abstract][Full Text] [Related]
9. Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor.
Bade LK; Goldberg JE; Dehut HA; Hall MK; Schwertfeger KL
J Cell Sci; 2011 Sep; 124(Pt 18):3106-17. PubMed ID: 21868365
[TBL] [Abstract][Full Text] [Related]
10. Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells.
Oliveras-Ferraros C; Cufí S; Queralt B; Vazquez-Martin A; Martin-Castillo B; de Llorens R; Bosch-Barrera J; Brunet J; Menendez JA
Br J Cancer; 2012 Apr; 106(8):1406-14. PubMed ID: 22491422
[TBL] [Abstract][Full Text] [Related]
11. Expression of the epidermal growth factor system in human middle ear cholesteatoma.
Thorup MB; Munk M; Poulsen SS; Gaihede M; Nexo E; Sorensen BS; Ovesen T
Acta Otolaryngol; 2014 Feb; 134(2):124-34. PubMed ID: 24256036
[TBL] [Abstract][Full Text] [Related]
12. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
Zhang X; Diaz MR; Yee D
Breast Cancer Res Treat; 2013 Jun; 139(2):351-60. PubMed ID: 23686416
[TBL] [Abstract][Full Text] [Related]
13. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine.
Fukata M; Chen A; Klepper A; Krishnareddy S; Vamadevan AS; Thomas LS; Xu R; Inoue H; Arditi M; Dannenberg AJ; Abreu MT
Gastroenterology; 2006 Sep; 131(3):862-77. PubMed ID: 16952555
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor ligands as new extracellular targets for the metastasis-promoting S100A4 protein.
Klingelhöfer J; Møller HD; Sumer EU; Berg CH; Poulsen M; Kiryushko D; Soroka V; Ambartsumian N; Grigorian M; Lukanidin EM
FEBS J; 2009 Oct; 276(20):5936-48. PubMed ID: 19740107
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors.
Fukata M; Chen A; Vamadevan AS; Cohen J; Breglio K; Krishnareddy S; Hsu D; Xu R; Harpaz N; Dannenberg AJ; Subbaramaiah K; Cooper HS; Itzkowitz SH; Abreu MT
Gastroenterology; 2007 Dec; 133(6):1869-81. PubMed ID: 18054559
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of EGFR ligands on endocytic sorting of the receptor.
Roepstorff K; Grandal MV; Henriksen L; Knudsen SL; Lerdrup M; Grøvdal L; Willumsen BM; van Deurs B
Traffic; 2009 Aug; 10(8):1115-27. PubMed ID: 19531065
[TBL] [Abstract][Full Text] [Related]
17. Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor.
Good M; Sodhi CP; Egan CE; Afrazi A; Jia H; Yamaguchi Y; Lu P; Branca MF; Ma C; Prindle T; Mielo S; Pompa A; Hodzic Z; Ozolek JA; Hackam DJ
Mucosal Immunol; 2015 Sep; 8(5):1166-79. PubMed ID: 25899687
[TBL] [Abstract][Full Text] [Related]
18. The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced.
Sørensen BS; Tørring N; Bor MV; Nexø E
Mol Cell Biochem; 2004 May; 260(1-2):129-35. PubMed ID: 15228094
[TBL] [Abstract][Full Text] [Related]
19. Luteinizing hormone signaling in preovulatory follicles involves early activation of the epidermal growth factor receptor pathway.
Panigone S; Hsieh M; Fu M; Persani L; Conti M
Mol Endocrinol; 2008 Apr; 22(4):924-36. PubMed ID: 18187604
[TBL] [Abstract][Full Text] [Related]
20. Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells.
Willmarth NE; Ethier SP
J Biol Chem; 2006 Dec; 281(49):37728-37. PubMed ID: 17035230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
